The possible molecular regulation mechanism of CIK cells inhibiting the proliferation of Human Lung Adenocarcinoma NCL-H157 Cells

Abstract Cytokine-induced killer (CIK) cells were isolated and proliferation from human peripheral blood and cultured in appropriate growth medium. The biological characteristics of CIK cells were further determined by the characterization of surface markers by flow cytometry. CIK cells inhibited the proliferation of human lung adenocarcinoma NCL-H157 cells. Vascular endothelial growth factor (VEGF) expression was down-regulated in CIK cells co-cultured with NCL-H157 cells by western blotting analysis. Furthermore, in comparison with cells untreated by CIK, the NCL-H157 had a lower proliferation capacity. We proposed that the pharmacological mechanisms of NCL-H157 promoted by CIK can be estimated possibly with different biological significance that can be ascribed to down-regulated VEGF expression in vitro. The results suggest that the VEGF pathway guides developmental inhibiting of NCL-H157, and we speculate that the function of VEGF pathways is to guide NCL-H157 to inhibition by abundant CIK.

[1]  B. Liu,et al.  Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non‐small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination , 2016, Thoracic cancer.

[2]  G. Lu,et al.  [Clinical Efficacy of DC and CIK Immunotherapy Combined with Chemotherapy and Its Impact on Treg Cells in Newly Diagnosed Multiple Myeloma]. , 2015, Zhongguo shi yan xue ye xue za zhi.

[3]  K. Akashi,et al.  Clinical outcomes of a novel therapeutic vaccine with Tax peptide‐pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study , 2015, British journal of haematology.

[4]  Danni Y. Zhu,et al.  Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer. , 2015, International immunopharmacology.

[5]  Linping Xu,et al.  Efficacy of RetroNectin-Activated Cytokine-Induced Killer Cell Therapy in Metastatic Brain Tumor Patients , 2015, Oncology Research and Treatment.

[6]  Xin Xin,et al.  Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells , 2014, Thoracic cancer.

[7]  Jian-hua Hu,et al.  The clinical effects of dendritic cell vaccines combined with cytokine-induced killer cells intraperitoneal injected on patients with malignant ascites. , 2014, International journal of clinical and experimental medicine.

[8]  Yuping Zhang,et al.  Bioinformatics analysis and expression study of fumarate hydratase in lung cancer , 2014, Thoracic cancer.

[9]  Yingting He,et al.  Human leukocyte antigen-haploidentical donor-derived cytokine-induced killer cells are safe and prolong the survival of patients with advanced non-small cell lung cancer , 2014, Oncology letters.

[10]  Andressa Ardiani,et al.  Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway , 2014, Oncotarget.

[11]  Akbarzadeh Abolfazl,et al.  Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[12]  F. Yu,et al.  Increased hepcidin expression in non‐small cell lung cancer tissue and serum is associated with clinical stage , 2014, Thoracic cancer.

[13]  Yusuke Nakamura,et al.  Identification of Promiscuous KIF20A Long Peptides Bearing Both CD4+ and CD8+ T-cell Epitopes: KIF20A-Specific CD4+ T-cell Immunity in Patients with Malignant Tumor , 2013, Clinical Cancer Research.

[14]  Youmei Feng,et al.  Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis , 2013, The Journal of Immunology.

[15]  W. Piacibello,et al.  Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors , 2012, Expert opinion on biological therapy.

[16]  Hui Li,et al.  CD4+CD25+ Regulatory T Cells Decreased the Antitumor Activity of Cytokine-Induced Killer (CIK) Cells of Lung Cancer Patients , 2007, Journal of Clinical Immunology.

[17]  P. Escoubas.  Molecular diversification in spider venoms: A web of combinatorial peptide libraries , 2006, Molecular Diversity.

[18]  Oliver Ebert,et al.  Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12 , 1998, Cancer Immunology, Immunotherapy.

[19]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.